Joanna Applequist is a European Patent Attorney and has been working in the life sciences and chemistry industries since 2011. She specialises in the fields of cell- and molecular biology, pharmaceuticals and biotechnology.
Joanna works in close collaboration with clients and inventors. Her main focus areas are biological and small molecule pharmaceuticals, protein engineering, antibodies, immunology, vaccine development, cell therapy as well as stem cells and neurobiology.
Joanna is involved in drafting and prosecution of patent applications, patentability evaluations, IP strategies, Freedom to Operate (FTO) analyses and IP due diligence.
She has a M.Sc. in Engineering Biology and received her Ph.D. in Cell and Molecular Biology from the Karolinska Institute. Joanna has a particularly deep understanding of developmental biology and neurobiology, including stem cells and cell differentiation from her time as an academic researcher.
Joanna is also an experienced lecturer and provides expert patent analysis and commentary to leading industry publications on topics such as Crispr-Cas9 technology.
- Analyses & searches
- IP due diligence
- IP Strategy
- Patent, prosecution
- Life sciences
- Biochemistry/Molecular Biology
- European Patent Attorney, Valea, 2018-2019
- European Patent Attorney, Groth & Co, 2017-2018
- Patent Attorney, AWA, 2011-2017
- Post-Doctoral Research Fellow, Karolinska Institute, 2011
- Master Thesis in Developmental Biology, University of Cambridge, United Kingdom, 2002
- Ph.D. Cell and Molecular Biology, Karolinska Institute, 2011
- M.Sc. Engineering Biology, Umeå University, 2002
- European Patent Attorney
- epi (Institute of Professional Representatives before the European Patent Office)
- SFIR (Swedish Association for the Protection of Industrial Property)
- AIPPI Sweden (International Association for the Protection of Intellectual Property)